Literature DB >> 29559743

Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.

Tianhong Su1, Junbin Liao1, Zihao Dai1, Lixia Xu2, Shuling Chen3, Yifei Wang1, Zhenwei Peng4, Qiuyang Zhang5, Sui Peng6,7, Ming Kuang8,9.   

Abstract

Recent studies indicated that insufficient radiofrequency ablation (RFA) could endow hepatocellular carcinoma (HCC) with higher aggressive potential. Stress-induced phosphoprotein 1 (STIP1), which was found highly expressed in HCC, is a chaperone molecule mediating cell homeostasis under thermal stress. We aimed to explore the role of STIP1 on the metastasis of residual HCC after RFA. Mice model with orthotopic HCC implants or caudal vein injection were employed to assess potential of lung metastasis and/or intrahepatic metastasis (IHM) of HCC cells. Cell culture model was used to determine cell invasion, mesenchymal marker genes expression, and underlying molecular mechanisms. Clinical specimens were collected to analyze the relationship between STIP1 and clinical outcome. We found that insufficient RFA elicited more IHM of HCCLM3 tumors, which could be reduced by silencing STIP1. Knockdown of STIP1 also significantly decreased lung metastatic potential of HCCLM3 cells. In vitro, HCCLM3 and HepG2 displayed a spindle-shaped morphology with upregulation of STIP1 and mesenchymal markers after sublethal heat exposure. Mechanistically, heat exposure induced the formation of STIP1-heat shock protein 90 (HSP90) complex, which could shuttle epithelial transcription repressor Snail1 into nucleus and regulate mesenchymal gene transcription. Blocking the HSP90-STIP1 complex reduced the invasive potential of HCC cells after heat exposure. Using clinical specimen, we found that STIP1 was expressed significantly higher in metastatic tumor tissues and in sera from metastatic HCC patients (p < 0.05). The high expression of STIP1 was significantly linked to shorter recurrence-free survival (p < 0.05). To sum up, our study found that STIP1 is positively associated with the sublethal heat-induced cancer cell metastasis through mediating the mesenchymal gene transcription. Blocking STIP1 activity may suppress HCC cell metastatic potential after RFA.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29559743     DOI: 10.1038/s41388-018-0169-4

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation.

Authors:  Tzu-Hao Wang; Angel Chao; Chia-Lung Tsai; Chih-Long Chang; Shun-Hua Chen; Yun-Shien Lee; Jen-Kun Chen; Yi-Jun Lin; Pi-Yueh Chang; Chin-Jung Wang; An-Shine Chao; Shuenn-Dyh Chang; Ting-Chang Chang; Chyong-Huey Lai; Hsin-Shih Wang
Journal:  Mol Cell Proteomics       Date:  2010-05-25       Impact factor: 5.911

2.  Quantification of mRNA Levels Using Real-Time Polymerase Chain Reaction (PCR).

Authors:  Yiyi Li; Kai Wang; Longhua Chen; Xiaoxia Zhu; Jie Zhou
Journal:  Methods Mol Biol       Date:  2016

Review 3.  Heat shock factor 1 in protein homeostasis and oncogenic signal integration.

Authors:  Trisha Home; Roy A Jensen; Rekha Rao
Journal:  Cancer Res       Date:  2015-02-27       Impact factor: 12.701

4.  Development of a high-throughput screening cancer cell-based luciferase refolding assay for identifying Hsp90 inhibitors.

Authors:  Takrima Sadikot; Megan Swink; Jeffery D Eskew; Douglas Brown; Huiping Zhao; Bhaskar R Kusuma; Roger A Rajewski; Brian S J Blagg; Robert L Matts; Jeffrey M Holzbeierlein; George A Vielhauer
Journal:  Assay Drug Dev Technol       Date:  2013-10-15       Impact factor: 1.738

5.  Rapid progression of hepatocellular carcinoma after Radiofrequency Ablation.

Authors:  Andrea Ruzzenente; Giovanni De Manzoni; Matteo Molfetta; Silvia Pachera; Bruno Genco; Matteo Donataccio; Alfredo Guglielmi
Journal:  World J Gastroenterol       Date:  2004-04-15       Impact factor: 5.742

6.  Autocrine STIP1 signaling promotes tumor growth and is associated with disease outcome in hepatocellular carcinoma.

Authors:  Zebin Chen; Lixia Xu; Tianhong Su; Zunfu Ke; Zhenwei Peng; Ning Zhang; Sui Peng; Qiuyang Zhang; Gengxun Liu; Guangyan Wei; Yu Guo; Minghui He; Ming Kuang
Journal:  Biochem Biophys Res Commun       Date:  2017-09-05       Impact factor: 3.575

7.  Rapid and aggressive recurrence accompanied by portal tumor thrombus after radiofrequency ablation for hepatocellular carcinoma.

Authors:  Yasutsugu Takada; Masanao Kurata; Nobuhiro Ohkohchi
Journal:  Int J Clin Oncol       Date:  2003-10       Impact factor: 3.402

8.  Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients.

Authors:  Hiroshi Kasugai; Yukio Osaki; Hiroko Oka; Masatoshi Kudo; Toshihito Seki
Journal:  Oncology       Date:  2007-12-13       Impact factor: 2.935

9.  HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer.

Authors:  R Schulz; F Streller; A H Scheel; J Rüschoff; M-C Reinert; M Dobbelstein; N D Marchenko; U M Moll
Journal:  Cell Death Dis       Date:  2014-01-02       Impact factor: 8.469

10.  Relative quantification of mRNA: comparison of methods currently used for real-time PCR data analysis.

Authors:  Stefan Cikos; Alexandra Bukovská; Juraj Koppel
Journal:  BMC Mol Biol       Date:  2007-12-20       Impact factor: 2.946

View more
  10 in total

1.  Insufficient ablation induces E3-ligase Nedd4 to promote hepatocellular carcinoma progression by tuning TGF-β signaling.

Authors:  Kai Li; Yi Niu; Yichuan Yuan; Jiliang Qiu; Yunxing Shi; Chengrui Zhong; Zhiyu Qiu; Keren Li; Zhu Lin; Zhenkun Huang; Chao Zhang; Dinglan Zuo; Wei He; Yunfei Yuan; Binkui Li
Journal:  Oncogene       Date:  2022-04-30       Impact factor: 9.867

2.  Serum STIP1, a Novel Indicator for Microvascular Invasion, Predicts Outcomes and Treatment Response in Hepatocellular Carcinoma.

Authors:  Xiao-Lu Ma; Wei-Guo Tang; Min-Jie Yang; Su-Hong Xie; Min-Le Wu; Guo Lin; Ren-Quan Lu
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

3.  Augmented EPR effect post IRFA to enhance the therapeutic efficacy of arsenic loaded ZIF-8 nanoparticles on residual HCC progression.

Authors:  Xuehua Chen; Yongquan Huang; Hui Chen; Ziman Chen; Jiaxin Chen; Hao Wang; Dan Li; Zhongzhen Su
Journal:  J Nanobiotechnology       Date:  2022-01-15       Impact factor: 9.429

Review 4.  Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go.

Authors:  Kunpeng Wang; Cong Wang; Hao Jiang; Yaqiong Zhang; Weidong Lin; Jinggang Mo; Chong Jin
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

Review 5.  The Hsp70-Hsp90 go-between Hop/Stip1/Sti1 is a proteostatic switch and may be a drug target in cancer and neurodegeneration.

Authors:  Kaushik Bhattacharya; Didier Picard
Journal:  Cell Mol Life Sci       Date:  2021-10-22       Impact factor: 9.261

Review 6.  An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation.

Authors:  Yusheng Guo; Yanqiao Ren; Xiangjun Dong; Xuefeng Kan; Chuansheng Zheng
Journal:  J Hepatocell Carcinoma       Date:  2022-04-26

7.  HIF-2α regulates proliferation, invasion, and metastasis of hepatocellular carcinoma cells via VEGF/Notch1 signaling axis after insufficient radiofrequency ablation.

Authors:  Yongguang Yang; Weifeng Chen; Weiheng Mai; Yi Gao
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

8.  FKBP4 is a malignant indicator in luminal A subtype of breast cancer.

Authors:  Hanchu Xiong; Zihan Chen; Wenwen Zheng; Jing Sun; Qingshuang Fu; Rongyue Teng; Jida Chen; Shuduo Xie; Linbo Wang; Xiao-Fang Yu; Jichun Zhou
Journal:  J Cancer       Date:  2020-01-16       Impact factor: 4.207

9.  Amarogentin Inhibits Liver Cancer Cell Angiogenesis after Insufficient Radiofrequency Ablation via Affecting Stemness and the p53-Dependent VEGFA/Dll4/Notch1 Pathway.

Authors:  Yongchuan Zhang; Yinglin Zhang; Jin Wang; Haitao Gu
Journal:  Biomed Res Int       Date:  2020-10-20       Impact factor: 3.411

10.  Intracellular targeting of STIP1 inhibits human cancer cell line growth.

Authors:  Chiao-Yun Lin; Shun-Hua Chen; Chia-Lung Tsai; Yun-Hsin Tang; Kai-Yun Wu; Angel Chao
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.